The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmaceutical Products and CMO Market Research Report 2024
Synopsis
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Pharmaceutical Products and CMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Products and CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Products and CMO.
Report Scope
The Pharmaceutical Products and CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Products and CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Products and CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Active Pharmaceutical Ingredient (API)
Finished Dosage Form (FDF)
Segment by Application
Large Enterprises
SMEs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Products and CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
The global Pharmaceutical Products and CMO market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Products and CMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Products and CMO.
Report Scope
The Pharmaceutical Products and CMO market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmaceutical Products and CMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Products and CMO companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant
Segment by Type
Active Pharmaceutical Ingredient (API)
Finished Dosage Form (FDF)
Segment by Application
Large Enterprises
SMEs
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmaceutical Products and CMO companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Products and CMO Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Active Pharmaceutical Ingredient (API)
1.2.3 Finished Dosage Form (FDF)
1.3 Market by Application
1.3.1 Global Pharmaceutical Products and CMO Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Large Enterprises
1.3.3 SMEs
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Products and CMO Market Perspective (2019-2030)
2.2 Pharmaceutical Products and CMO Growth Trends by Region
2.2.1 Global Pharmaceutical Products and CMO Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmaceutical Products and CMO Historic Market Size by Region (2019-2024)
2.2.3 Pharmaceutical Products and CMO Forecasted Market Size by Region (2025-2030)
2.3 Pharmaceutical Products and CMO Market Dynamics
2.3.1 Pharmaceutical Products and CMO Industry Trends
2.3.2 Pharmaceutical Products and CMO Market Drivers
2.3.3 Pharmaceutical Products and CMO Market Challenges
2.3.4 Pharmaceutical Products and CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Products and CMO Players by Revenue
3.1.1 Global Top Pharmaceutical Products and CMO Players by Revenue (2019-2024)
3.1.2 Global Pharmaceutical Products and CMO Revenue Market Share by Players (2019-2024)
3.2 Global Pharmaceutical Products and CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical Products and CMO Revenue
3.4 Global Pharmaceutical Products and CMO Market Concentration Ratio
3.4.1 Global Pharmaceutical Products and CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Products and CMO Revenue in 2023
3.5 Pharmaceutical Products and CMO Key Players Head office and Area Served
3.6 Key Players Pharmaceutical Products and CMO Product Solution and Service
3.7 Date of Enter into Pharmaceutical Products and CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Products and CMO Breakdown Data by Type
4.1 Global Pharmaceutical Products and CMO Historic Market Size by Type (2019-2024)
4.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2025-2030)
5 Pharmaceutical Products and CMO Breakdown Data by Application
5.1 Global Pharmaceutical Products and CMO Historic Market Size by Application (2019-2024)
5.2 Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmaceutical Products and CMO Market Size (2019-2030)
6.2 North America Pharmaceutical Products and CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmaceutical Products and CMO Market Size by Country (2019-2024)
6.4 North America Pharmaceutical Products and CMO Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Products and CMO Market Size (2019-2030)
7.2 Europe Pharmaceutical Products and CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmaceutical Products and CMO Market Size by Country (2019-2024)
7.4 Europe Pharmaceutical Products and CMO Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Products and CMO Market Size (2019-2030)
8.2 Asia-Pacific Pharmaceutical Products and CMO Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Products and CMO Market Size (2019-2030)
9.2 Latin America Pharmaceutical Products and CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmaceutical Products and CMO Market Size by Country (2019-2024)
9.4 Latin America Pharmaceutical Products and CMO Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Products and CMO Market Size (2019-2030)
10.2 Middle East & Africa Pharmaceutical Products and CMO Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Products and CMO Introduction
11.1.4 Catalent Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Pharmaceutical Products and CMO Introduction
11.2.4 Thermo Fisher Scientific Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Pharmaceutical Products and CMO Introduction
11.3.4 Lonza Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Boehringer Ingelheim
11.4.1 Boehringer Ingelheim Company Detail
11.4.2 Boehringer Ingelheim Business Overview
11.4.3 Boehringer Ingelheim Pharmaceutical Products and CMO Introduction
11.4.4 Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.4.5 Boehringer Ingelheim Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical Products and CMO Introduction
11.5.4 Fareva Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.5.5 Fareva Recent Development
11.6 Recipharm
11.6.1 Recipharm Company Detail
11.6.2 Recipharm Business Overview
11.6.3 Recipharm Pharmaceutical Products and CMO Introduction
11.6.4 Recipharm Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.6.5 Recipharm Recent Development
11.7 Aenova
11.7.1 Aenova Company Detail
11.7.2 Aenova Business Overview
11.7.3 Aenova Pharmaceutical Products and CMO Introduction
11.7.4 Aenova Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.7.5 Aenova Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Detail
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Pharmaceutical Products and CMO Introduction
11.8.4 AbbVie Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.8.5 AbbVie Recent Development
11.9 Baxter
11.9.1 Baxter Company Detail
11.9.2 Baxter Business Overview
11.9.3 Baxter Pharmaceutical Products and CMO Introduction
11.9.4 Baxter Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.9.5 Baxter Recent Development
11.10 Nipro Corp
11.10.1 Nipro Corp Company Detail
11.10.2 Nipro Corp Business Overview
11.10.3 Nipro Corp Pharmaceutical Products and CMO Introduction
11.10.4 Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.10.5 Nipro Corp Recent Development
11.11 Sopharma
11.11.1 Sopharma Company Detail
11.11.2 Sopharma Business Overview
11.11.3 Sopharma Pharmaceutical Products and CMO Introduction
11.11.4 Sopharma Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.11.5 Sopharma Recent Development
11.12 Famar
11.12.1 Famar Company Detail
11.12.2 Famar Business Overview
11.12.3 Famar Pharmaceutical Products and CMO Introduction
11.12.4 Famar Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.12.5 Famar Recent Development
11.13 Vetter
11.13.1 Vetter Company Detail
11.13.2 Vetter Business Overview
11.13.3 Vetter Pharmaceutical Products and CMO Introduction
11.13.4 Vetter Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.13.5 Vetter Recent Development
11.14 Shandong Xinhua
11.14.1 Shandong Xinhua Company Detail
11.14.2 Shandong Xinhua Business Overview
11.14.3 Shandong Xinhua Pharmaceutical Products and CMO Introduction
11.14.4 Shandong Xinhua Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.14.5 Shandong Xinhua Recent Development
11.15 Piramal
11.15.1 Piramal Company Detail
11.15.2 Piramal Business Overview
11.15.3 Piramal Pharmaceutical Products and CMO Introduction
11.15.4 Piramal Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.15.5 Piramal Recent Development
11.16 Mylan
11.16.1 Mylan Company Detail
11.16.2 Mylan Business Overview
11.16.3 Mylan Pharmaceutical Products and CMO Introduction
11.16.4 Mylan Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.16.5 Mylan Recent Development
11.17 Dr. Reddy’s
11.17.1 Dr. Reddy’s Company Detail
11.17.2 Dr. Reddy’s Business Overview
11.17.3 Dr. Reddy’s Pharmaceutical Products and CMO Introduction
11.17.4 Dr. Reddy’s Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.17.5 Dr. Reddy’s Recent Development
11.18 Zhejiang Hisun
11.18.1 Zhejiang Hisun Company Detail
11.18.2 Zhejiang Hisun Business Overview
11.18.3 Zhejiang Hisun Pharmaceutical Products and CMO Introduction
11.18.4 Zhejiang Hisun Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.18.5 Zhejiang Hisun Recent Development
11.19 Zhejiang Huahai
11.19.1 Zhejiang Huahai Company Detail
11.19.2 Zhejiang Huahai Business Overview
11.19.3 Zhejiang Huahai Pharmaceutical Products and CMO Introduction
11.19.4 Zhejiang Huahai Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.19.5 Zhejiang Huahai Recent Development
11.20 Jubilant
11.20.1 Jubilant Company Detail
11.20.2 Jubilant Business Overview
11.20.3 Jubilant Pharmaceutical Products and CMO Introduction
11.20.4 Jubilant Revenue in Pharmaceutical Products and CMO Business (2019-2024)
11.20.5 Jubilant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pharmaceutical Products and CMO Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Active Pharmaceutical Ingredient (API)
Table 3. Key Players of Finished Dosage Form (FDF)
Table 4. Global Pharmaceutical Products and CMO Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pharmaceutical Products and CMO Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pharmaceutical Products and CMO Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pharmaceutical Products and CMO Market Share by Region (2019-2024)
Table 8. Global Pharmaceutical Products and CMO Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pharmaceutical Products and CMO Market Share by Region (2025-2030)
Table 10. Pharmaceutical Products and CMO Market Trends
Table 11. Pharmaceutical Products and CMO Market Drivers
Table 12. Pharmaceutical Products and CMO Market Challenges
Table 13. Pharmaceutical Products and CMO Market Restraints
Table 14. Global Pharmaceutical Products and CMO Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pharmaceutical Products and CMO Market Share by Players (2019-2024)
Table 16. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2023)
Table 17. Ranking of Global Top Pharmaceutical Products and CMO Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pharmaceutical Products and CMO Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmaceutical Products and CMO Product Solution and Service
Table 21. Date of Enter into Pharmaceutical Products and CMO Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmaceutical Products and CMO Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2019-2024)
Table 25. Global Pharmaceutical Products and CMO Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pharmaceutical Products and CMO Revenue Market Share by Type (2025-2030)
Table 27. Global Pharmaceutical Products and CMO Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2019-2024)
Table 29. Global Pharmaceutical Products and CMO Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pharmaceutical Products and CMO Revenue Market Share by Application (2025-2030)
Table 31. North America Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pharmaceutical Products and CMO Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pharmaceutical Products and CMO Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pharmaceutical Products and CMO Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pharmaceutical Products and CMO Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pharmaceutical Products and CMO Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical Products and CMO Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pharmaceutical Products and CMO Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pharmaceutical Products and CMO Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pharmaceutical Products and CMO Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical Products and CMO Market Size by Country (2025-2030) & (US$ Million)
Table 46. Catalent Company Detail
Table 47. Catalent Business Overview
Table 48. Catalent Pharmaceutical Products and CMO Product
Table 49. Catalent Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 50. Catalent Recent Development
Table 51. Thermo Fisher Scientific Company Detail
Table 52. Thermo Fisher Scientific Business Overview
Table 53. Thermo Fisher Scientific Pharmaceutical Products and CMO Product
Table 54. Thermo Fisher Scientific Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 55. Thermo Fisher Scientific Recent Development
Table 56. Lonza Company Detail
Table 57. Lonza Business Overview
Table 58. Lonza Pharmaceutical Products and CMO Product
Table 59. Lonza Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 60. Lonza Recent Development
Table 61. Boehringer Ingelheim Company Detail
Table 62. Boehringer Ingelheim Business Overview
Table 63. Boehringer Ingelheim Pharmaceutical Products and CMO Product
Table 64. Boehringer Ingelheim Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 65. Boehringer Ingelheim Recent Development
Table 66. Fareva Company Detail
Table 67. Fareva Business Overview
Table 68. Fareva Pharmaceutical Products and CMO Product
Table 69. Fareva Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 70. Fareva Recent Development
Table 71. Recipharm Company Detail
Table 72. Recipharm Business Overview
Table 73. Recipharm Pharmaceutical Products and CMO Product
Table 74. Recipharm Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 75. Recipharm Recent Development
Table 76. Aenova Company Detail
Table 77. Aenova Business Overview
Table 78. Aenova Pharmaceutical Products and CMO Product
Table 79. Aenova Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 80. Aenova Recent Development
Table 81. AbbVie Company Detail
Table 82. AbbVie Business Overview
Table 83. AbbVie Pharmaceutical Products and CMO Product
Table 84. AbbVie Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 85. AbbVie Recent Development
Table 86. Baxter Company Detail
Table 87. Baxter Business Overview
Table 88. Baxter Pharmaceutical Products and CMO Product
Table 89. Baxter Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 90. Baxter Recent Development
Table 91. Nipro Corp Company Detail
Table 92. Nipro Corp Business Overview
Table 93. Nipro Corp Pharmaceutical Products and CMO Product
Table 94. Nipro Corp Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 95. Nipro Corp Recent Development
Table 96. Sopharma Company Detail
Table 97. Sopharma Business Overview
Table 98. Sopharma Pharmaceutical Products and CMO Product
Table 99. Sopharma Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 100. Sopharma Recent Development
Table 101. Famar Company Detail
Table 102. Famar Business Overview
Table 103. Famar Pharmaceutical Products and CMO Product
Table 104. Famar Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 105. Famar Recent Development
Table 106. Vetter Company Detail
Table 107. Vetter Business Overview
Table 108. Vetter Pharmaceutical Products and CMO Product
Table 109. Vetter Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 110. Vetter Recent Development
Table 111. Shandong Xinhua Company Detail
Table 112. Shandong Xinhua Business Overview
Table 113. Shandong Xinhua Pharmaceutical Products and CMO Product
Table 114. Shandong Xinhua Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 115. Shandong Xinhua Recent Development
Table 116. Piramal Company Detail
Table 117. Piramal Business Overview
Table 118. Piramal Pharmaceutical Products and CMO Product
Table 119. Piramal Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 120. Piramal Recent Development
Table 121. Mylan Company Detail
Table 122. Mylan Business Overview
Table 123. Mylan Pharmaceutical Products and CMO Product
Table 124. Mylan Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 125. Mylan Recent Development
Table 126. Dr. Reddy’s Company Detail
Table 127. Dr. Reddy’s Business Overview
Table 128. Dr. Reddy’s Pharmaceutical Products and CMO Product
Table 129. Dr. Reddy’s Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 130. Dr. Reddy’s Recent Development
Table 131. Zhejiang Hisun Company Detail
Table 132. Zhejiang Hisun Business Overview
Table 133. Zhejiang Hisun Pharmaceutical Products and CMO Product
Table 134. Zhejiang Hisun Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 135. Zhejiang Hisun Recent Development
Table 136. Zhejiang Huahai Company Detail
Table 137. Zhejiang Huahai Business Overview
Table 138. Zhejiang Huahai Pharmaceutical Products and CMO Product
Table 139. Zhejiang Huahai Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 140. Zhejiang Huahai Recent Development
Table 141. Jubilant Company Detail
Table 142. Jubilant Business Overview
Table 143. Jubilant Pharmaceutical Products and CMO Product
Table 144. Jubilant Revenue in Pharmaceutical Products and CMO Business (2019-2024) & (US$ Million)
Table 145. Jubilant Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical Products and CMO Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pharmaceutical Products and CMO Market Share by Type: 2023 VS 2030
Figure 3. Active Pharmaceutical Ingredient (API) Features
Figure 4. Finished Dosage Form (FDF) Features
Figure 5. Global Pharmaceutical Products and CMO Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Pharmaceutical Products and CMO Market Share by Application: 2023 VS 2030
Figure 7. Large Enterprises Case Studies
Figure 8. SMEs Case Studies
Figure 9. Pharmaceutical Products and CMO Report Years Considered
Figure 10. Global Pharmaceutical Products and CMO Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Pharmaceutical Products and CMO Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Pharmaceutical Products and CMO Market Share by Region: 2023 VS 2030
Figure 13. Global Pharmaceutical Products and CMO Market Share by Players in 2023
Figure 14. Global Top Pharmaceutical Products and CMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Products and CMO as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Pharmaceutical Products and CMO Revenue in 2023
Figure 16. North America Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Pharmaceutical Products and CMO Market Share by Country (2019-2030)
Figure 18. United States Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Pharmaceutical Products and CMO Market Share by Country (2019-2030)
Figure 22. Germany Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Pharmaceutical Products and CMO Market Share by Region (2019-2030)
Figure 30. China Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Pharmaceutical Products and CMO Market Share by Country (2019-2030)
Figure 38. Mexico Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Pharmaceutical Products and CMO Market Share by Country (2019-2030)
Figure 42. Turkey Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Pharmaceutical Products and CMO Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Catalent Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 46. Lonza Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 48. Fareva Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 49. Recipharm Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 50. Aenova Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 51. AbbVie Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 52. Baxter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 53. Nipro Corp Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 54. Sopharma Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 55. Famar Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 56. Vetter Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 57. Shandong Xinhua Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 58. Piramal Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 59. Mylan Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 60. Dr. Reddy’s Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 61. Zhejiang Hisun Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 62. Zhejiang Huahai Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 63. Jubilant Revenue Growth Rate in Pharmaceutical Products and CMO Business (2019-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
